Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 71335-2992

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 71335-2992). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
A scatter plot chart titled 'Special Population' analyzing pharmacokinetic parameters of venlafaxine and its O-desmethylvenlafaxine (ODV) metabolite. It shows fold changes with 90% confidence intervals in Cmax and AUC for various populations, including hepatic and renal impairments, CYP2D6 metabolizer status, age over 60, and gender differences, relative to reference values.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A dot plot chart showing pharmacokinetic (PK) changes in venlafaxine and its metabolite ODV when interacting with various drugs. The chart compares fold changes with 90% confidence intervals for parameters such as Cmax and AUC, indicating changes relative to a reference value for drugs like ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
A scatter plot depicting the fold change and 90% confidence intervals of pharmacokinetic parameters Cmax and AUC for various analytes when exposed to different interacting drugs, relative to a reference value. The interacting drugs, analytes, and parameters are listed on the left, with fold changes shown on the horizontal axis, ranging approximately from 0 to 3.*
FDA Label Image

Label (Lbl713352992)

Label (Lbl713352992)
Label for Venlafaxine Hydrochloride Extended-Release Capsules USP, 150 mg strength, containing 30 capsules. The label includes NDC 71335-2992-1 and states the product is repackaged by Bryant Ranch Prepack, Inc., Burbank, CA, and manufactured by Granules India Limited. Storage instructions and warnings about keeping drugs out of children's reach are also visible.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of venlafaxine hydrochloride shown as a 2D molecular diagram. The image includes labeled atoms and bonds indicating the molecular arrangement specific to the active ingredient venlafaxine hydrochloride.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.